Cullinan Therapeutics, Inc. - Common Stock (CGEM)
CUSIP: 230031106
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 59,091,689
- Total 13F shares
- 32,250,659
- Share change
- +913,316
- Total reported value
- $828,539,736
- Price per share
- $25.75
- Number of holders
- 70
- Value change
- -$17,650,444
- Number of buys
- 38
- Number of sells
- 36
Quarterly Holders Quick Answers
What is CUSIP 230031106?
CUSIP 230031106 identifies CGEM - Cullinan Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 230031106:
Top shareholders of CGEM - Cullinan Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MPM BioImpact LLC |
13F
|
Company |
13%
|
7,913,887
|
$329,772,000 | — | 31 Mar 2021 | |
| Foresite Capital Management V, LLC |
13F
|
Company |
4.6%
|
2,731,410
|
$113,818,000 | — | 31 Mar 2021 | |
| CHI Advisors LLC |
13F
|
Company |
3.7%
|
2,202,407
|
$91,774,000 | — | 31 Mar 2021 | |
| BAUPOST GROUP LLC/MA |
13F
|
Company |
3.1%
|
1,835,560
|
$71,699,000 | — | 31 Mar 2021 | |
| FMR LLC |
13F
|
Company |
2.1%
|
1,220,174
|
$50,845,000 | — | 31 Mar 2021 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
1,212,555
|
$49,025,000 | — | 31 Mar 2021 | |
| VR Adviser, LLC |
13F
|
Company |
2%
|
1,176,145
|
$49,010,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.9%
|
1,151,287
|
$47,974,000 | — | 31 Mar 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.9%
|
1,146,145
|
$47,760,000 | — | 31 Mar 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.8%
|
1,075,912
|
$44,833,000 | — | 31 Mar 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
1.8%
|
1,074,082
|
$44,757,000 | — | 31 Mar 2021 | |
| BVF INC/IL |
13F
|
Company |
1.8%
|
1,049,356
|
$43,727,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.5%
|
887,808
|
$36,995,000 | — | 31 Mar 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.2%
|
723,584
|
$30,152,000 | — | 31 Mar 2021 | |
| Avidity Partners Management LP |
13F
|
Company |
1.2%
|
707,359
|
$29,476,000 | — | 31 Mar 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.92%
|
542,912
|
$22,623,000 | — | 31 Mar 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.83%
|
488,308
|
$20,348,000 | — | 31 Mar 2021 | |
| Logos Global Management LP |
13F
|
Company |
0.7%
|
413,458
|
$17,229,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.68%
|
403,836
|
$16,828,000 | — | 31 Mar 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.59%
|
350,000
|
$14,585,000 | — | 31 Mar 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.58%
|
341,731
|
$14,240,000 | — | 31 Mar 2021 | |
| Vivo Capital, LLC |
13F
|
Company |
0.42%
|
250,000
|
$10,418,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.37%
|
220,267
|
$9,178,000 | — | 31 Mar 2021 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.37%
|
216,630
|
$9,027,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.33%
|
194,815
|
$8,118,000 | — | 31 Mar 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.29%
|
173,471
|
$7,229,000 | — | 31 Mar 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.26%
|
154,539
|
$6,440,000 | — | 31 Mar 2021 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.25%
|
150,000
|
$6,250,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.24%
|
141,240
|
$5,885,000 | — | 31 Mar 2021 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.21%
|
125,000
|
$5,209,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.19%
|
111,322
|
$4,639,000 | — | 31 Mar 2021 | |
| Artal Group S.A. |
13F
|
Company |
0.17%
|
100,000
|
$4,167,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.15%
|
86,431
|
$3,602,000 | — | 31 Mar 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.11%
|
64,033
|
$2,668,000 | — | 31 Mar 2021 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.11%
|
64,000
|
$2,667,000 | — | 31 Mar 2021 | |
| Birchview Capital, LP |
13F
|
Company |
0.1%
|
60,114
|
$2,505,000 | — | 31 Mar 2021 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.1%
|
60,000
|
$2,500,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.09%
|
56,060
|
$2,336,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.08%
|
49,736
|
$2,073,000 | — | 31 Mar 2021 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.08%
|
48,373
|
$2,017,000 | — | 31 Mar 2021 | |
| J. Goldman & Co LP |
13F
|
Company |
0.07%
|
42,539
|
$1,773,000 | — | 31 Mar 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.06%
|
38,201
|
$1,592,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.06%
|
34,825
|
$1,451,000 | — | 31 Mar 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.06%
|
34,670
|
$1,445,000 | — | 31 Mar 2021 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.04%
|
25,000
|
$1,042,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
23,335
|
$972,000 | — | 31 Mar 2021 | |
| Laurion Capital Management LP |
13F
|
Company |
0.04%
|
21,000
|
$875,000 | — | 31 Mar 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
19,797
|
$825,000 | — | 31 Mar 2021 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.03%
|
18,739
|
$781,000 | — | 31 Mar 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
11,584
|
$483,000 | — | 31 Mar 2021 |
Institutional Holders of Cullinan Therapeutics, Inc. - Common Stock (CGEM) as of Q2 2021
As of 30 Jun 2021,
Cullinan Therapeutics, Inc. - Common Stock (CGEM) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,250,659 shares.
The largest 10 holders included
MPM Oncology Impact Management LP, Foresite Capital Management V, LLC, CHI Advisors LLC, FMR LLC, BAUPOST GROUP LLC/MA, EVENTIDE ASSET MANAGEMENT, LLC, AMERICAN INTERNATIONAL GROUP, INC., VANGUARD GROUP INC, ORBIMED ADVISORS LLC, and Rock Springs Capital Management LP.
This page lists
70
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
70
Q2 2021 holders
70
Holder diff
0
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.